New asthma drug shows promise in Real-World spanish study

NCT ID NCT06487065

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how well tezepelumab works for people with severe asthma when used in everyday medical practice, outside of a clinical trial. Researchers tracked 33 patients in Spain who received the drug through a special access program. The goal was to see how the drug affected asthma attacks, lung function, and other health measures over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEVERE ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma chronic asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Research Site

    Alcázar de San Juan, Spain

  • Research Site

    Almería, Spain

  • Research Site

    Badajoz, Spain

  • Research Site

    Bilbao, Spain

  • Research Site

    Coslada, Spain

  • Research Site

    Donostia / San Sebastian, Spain

  • Research Site

    Fuenlabrada, Spain

  • Research Site

    Gran Canaria, Spain

  • Research Site

    Lugo, Spain

  • Research Site

    Madrid, Spain

  • Research Site

    Málaga, Spain

  • Research Site

    Talavera de la Reina, Spain

  • Research Site

    Torrejón de Ardoz, Spain

  • Research Site

    Valencia, Spain